HORIZON EUROPE
Europeo
Scope:Specific challenge
To control the epidemic, ensuring vaccination coverage is of critical importance. In addition, to ensure lasting protection, a booster dose with a heterologous vaccine may potentially be required. This creates additional challenges for compliance i.e. guaranteeing that the right vaccine dose is given at the right time. Furthermore, the countries mostly affected by the current epidemic experience a climate of distrust in vaccines. Lack of community acceptance represents a significant challenge that could potentially derail both vaccine trials and vaccine distribution.
Scope
The project will develop i) technologies and tools that augment the adherence to the vaccination regimen at individual level. It will also ii) look into environmental factors that impact compliance and look at how to favourably influence these at community level.
The project will be rolled out and operationalised during conduct of the large scale phase II and III vaccination trials conducted under Topic 1 of this Call to assess the safety and efficacy of a candidate vaccine. Those trials offer an opportunity to test and validate an...
ver más
Scope:Specific challenge
To control the epidemic, ensuring vaccination coverage is of critical importance. In addition, to ensure lasting protection, a booster dose with a heterologous vaccine may potentially be required. This creates additional challenges for compliance i.e. guaranteeing that the right vaccine dose is given at the right time. Furthermore, the countries mostly affected by the current epidemic experience a climate of distrust in vaccines. Lack of community acceptance represents a significant challenge that could potentially derail both vaccine trials and vaccine distribution.
Scope
The project will develop i) technologies and tools that augment the adherence to the vaccination regimen at individual level. It will also ii) look into environmental factors that impact compliance and look at how to favourably influence these at community level.
The project will be rolled out and operationalised during conduct of the large scale phase II and III vaccination trials conducted under Topic 1 of this Call to assess the safety and efficacy of a candidate vaccine. Those trials offer an opportunity to test and validate any new tools and technologies. One option can be to exploit the high penetration of mobile telecommunication and use of mobile apps in West Africa. Proposals that will use mobile communication strategies to increase awareness, acceptance and subject recruitment in the vaccination campaigns or will create specific apps to remind participants of their appointments and keep track of their response or side effects are encouraged. In this type of project it is essential to guarantee privacy of subjects. To that end the operation as such of the telecommunication infrastructure within the study needs to be clearly separated from the scientific work, for example by having different legal entities responsible for the different aspects.
Ethical considerations must also figure in the assessment, taking into account the health-systems context.
The project will develop specific tailor made communication programmes that should help with the overall acceptance of the vaccination programme, and increase the willingness of the community to fully comply with the vaccination regimen.
The scope of the project includes research on community vaccine acceptance and attitude towards vaccines.
Welcome are also considerations on how monitoring of adverse events could be put in place, and how vaccinees who get a fever should be handled.
It is considered that an IMI2 JU financial contribution of approximately 25 million and an EFPIA in-kind contribution of approximately EUR 25 million would allow this specific challenge to be addressed appropriately. Nevertheless, this does not preclude submission and selection of proposals requesting other amounts.
Expected impact
The proposed project is expected to provide a fully validated tool or system that captures critical information for each vaccinee (date, dose, batch no.), allows for automated recalls to the vaccinee for subsequent doses, central tracking of overall vaccination coverage and compliance, all in a user friendly, cost economic way.
Improved overall acceptance and a positive attitude towards vaccination programmes will facilitate the conduct of clinical trials in endemic regions, and will increase compliance and help to combat both the current epidemic and prevent outbreaks in the future.
Cross-cutting Priorities:International cooperation
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
Please note that submitting proposals for this call can only be done through the IMI SOFIA software tool.
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in theIMI2 Manual for evaluation, submission and grant award. See also the Commission Delegated Regulation (EU) N° 622/2014 of 14 February 2014
Evaluation
For a guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold: please see the IMI2 Manual for submission, evaluation and grant award
See also the IMI2 RIA Proposal Template and IMI2 RIA Evaluation Form in section 6, below.
Proposal page limits and layout: Please refer to IMI2 RIA Proposal Template in section 6, below
Indicative timetable for evaluation and grant agreement:
Information on the outcome of one-stage evaluation: maximum 2 months from the final date for submission.
Signature of grant agreements: maximum 1 month from the date of informing successful applicants.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under t... Please read the IMI2 2nd Call Topic Text for full details of this topic.
Please note that submitting proposals for this call can only be done through the IMI SOFIA software tool.
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in theIMI2 Manual for evaluation, submission and grant award. See also the Commission Delegated Regulation (EU) N° 622/2014 of 14 February 2014
Evaluation
For a guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold: please see the IMI2 Manual for submission, evaluation and grant award
See also the IMI2 RIA Proposal Template and IMI2 RIA Evaluation Form in section 6, below.
Proposal page limits and layout: Please refer to IMI2 RIA Proposal Template in section 6, below
Indicative timetable for evaluation and grant agreement:
Information on the outcome of one-stage evaluation: maximum 2 months from the final date for submission.
Signature of grant agreements: maximum 1 month from the date of informing successful applicants.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Summary of the most relevant provisions for participating in IMI2 actions
IMI2 RIA Proposal Template
IMI2 RIA Evaluation Form
IMI2 Model Grant Agreement
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta